ED Decision 2019/002/R
(a) In the case of malignant disease, applicants may be considered for a fit assessment if:
(1) there is no evidence of residual malignant disease likely to jeopardise flight safety;
(2) time appropriate to the type of tumour has elapsed since the end of primary treatment;
(3) the risk of in-flight incapacitation from a recurrence or metastasis is sufficiently low;
(4) there is no evidence of short or long-term sequelae from treatment that may jeopardise flight safety.
(b) Arrangements for an oncological follow-up should be made for an appropriate period of time.
(c) Applicants with an established history or clinical diagnosis of intracerebral malignant tumour should be assessed as unfit.
Loading collections...